Share the post "Epigral Limited’s Quarterly Result and Earnings Report for Q4(Mar 2024) : Key Metrics and Growth Analysis"
Highlights
- Sales over the Year and quarter: The company’s sales declined by -6.68% over the yearSubstantial increase in net sales/revenue by 11.26%.
- Income over the Year and quarter: There has been decline in other income over the past year which is -52.88% Marginal decrease of -4.91% in other income during this quarter
- Profit over the Year and quarter: Significant improvement in profitability for Epigral Limited. Notable increase of 0.71% in net profit Year to YearEpigral Limited’s profitability increased by 57.44% in this quarter.
- EPS over the Year and quarter: EPS increased by 0.70% Year to Year.EPS increased by 57.49%. Positive impact on shareholders.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 562.177 Cr | Rs. 471.52 Cr | Rs. 524.633 Cr | + 11.26% | -6.68% |
| Expenses | Rs. 407.51 Cr | Rs. 348.75 Cr | Rs. 369.24 Cr | + 5.88% | -9.39% |
| Operating Profit | Rs. 154.67 Cr | Rs. 122.77 Cr | Rs. 155.39 Cr | + 26.57% | + 0.47% |
| OPM % | 27.51 % | 26.04 % | 29.62 % | + 3.58% | + 2.11% |
| Other Income | Rs. 4.52 Cr | Rs. 2.24 Cr | Rs. 2.13 Cr | -4.91% | -52.88% |
| Interest | Rs. 18.99 Cr | Rs. 20.19 Cr | Rs. 13.69 Cr | -32.19% | -27.91% |
| Depreciation | Rs. 30.13 Cr | Rs. 30.88 Cr | Rs. 30.38 Cr | -1.62% | + 0.83% |
| Profit before tax | Rs. 110.07 Cr | Rs. 73.94 Cr | Rs. 113.45 Cr | + 53.44% | + 3.07% |
| Tax % | 30.28 % | 33.51 % | 32.06 % | -1.45% | + 1.78% |
| Net Profit | Rs. 76.73 Cr | Rs. 49.08 Cr | Rs. 77.28 Cr | + 57.46% | + 0.72% |
| EPS in Rs | Rs. 18.47 | Rs. 11.81 | Rs. 18.6 | + 57.49% | + 0.7% |
Today, we’re looking at Epigral Limited’s financial performance for the Q4(Mar 2024).Starting with the top line, the company reported a significant year-over-year sales decline of -6.68%. However, it did see a marginal increase of 11.26% from the previous quarter.Expenses ticked up slightly by 5.88% quarter-on-quarter, aligning with the annual decline of -9.39%. Operating profit, while up 0.47% compared to last year, faced a quarter-on-quarter increase of 26.57%, signaling a short-term expansion in margins.
The Operating Profit Margin (OPM) % echoes this narrative, showing resilience on an annual basis with an increase of 2.11%, but an expansion of 3.58% sequentially. Other income fell by -4.91% compared to the last quarter, despite an annual decline of -52.88%. Interest expenses dropped significantly by -32.19% from the previous quarter, yet the year-over-year decrease remains at a moderate -27.91%. Depreciation costs fell by -1.62% quarter-on-quarter, whereas on an annual scale, they saw an increase of 0.83%. Profit before tax grew annually by 3.07% but saw an increase from the preceding quarter by 53.44%.
Tax expenses as a percentage of profits increased slightly by 1.78% compared to last year, with a more notable quarter-on-quarter decrease of -1.45%. Net profit rose by 0.72% year-on-year but experienced a 57.46% expansion from the last quarter. And finally, Earnings Per Share (EPS) displayed an annual uptick of 0.7% but a quarterly rise of 57.49%. In summary, Epigral Limited’s annual performance indicates steady growth, although the quarter-on-quarter figures suggest some areas may require strategic attention.
| Metrics | Previous Year | Previous Quarter | Current Quarter | Quarter to Quarter Difference | Year to Year Difference |
|---|---|---|---|---|---|
| Sales | Rs. 562.177 Cr | Rs. 471.52 Cr | Rs. 524.633 Cr | + 11.26% | -6.68% |
| Expenses | Rs. 407.51 Cr | Rs. 348.75 Cr | Rs. 369.24 Cr | + 5.88% | -9.39% |
| Operating Profit | Rs. 154.67 Cr | Rs. 122.77 Cr | Rs. 155.39 Cr | + 26.57% | + 0.47% |
| Net Profit | Rs. 76.73 Cr | Rs. 49.08 Cr | Rs. 77.28 Cr | + 57.46% | + 0.72% |
| EPS in Rs | Rs. 18.47 | Rs. 11.81 | Rs. 18.6 | + 57.49% | + 0.7% |
In reviewing Epigral Limited’s 2024(Q4) financial snapshot, key trends emerge, shedding light on the company’s performance.Sales experienced a decrease of -6.68% year-on-year, however, there was a minor increase of 11.26% from the previous quarter. Expenses decreased by -9.39% compared to the previous year, with a 5.88% increase quarter-on-quarter. Operating Profit surged by 0.47% annually, and saw a 26.57% increase from the last quarter.
Net Profit showed yearly increase of 0.72%, and experienced a 57.46% increase from the previous quarter. Earnings Per Share (EPS) rose by 0.7% annually, however rose by 57.49% compared to the last quarter. In essence, while Epigral Limited exhibits strong annual growth indicators, short-term improvements suggest the potential for recovery and the importance of strategic adjustments to counter market challenges effectively. That’s all for now in the financial sector.
